EC backs first gene replacement therapy for broad sma population
Updated Date: Tue, 23 Jun 2026 00:00:00 EDT
QuantumCell gains global rights to NeuroRestore platform in deal worth over USD 2.2 billion
Experts join new group as therapy moves into phase 2b
Updated Date: Tue, 23 Jun 2026 00:00:00 EDT
Updated Date: Tue, 23 Jun 2026 00:00:00 EDT
Updated Date: Tue, 23 Jun 2026 00:00:00 EDT
Updated Date: Tue, 23 Jun 2026 00:00:00 EDT
IROS and partners use Emirati Genome Programme to identify high-risk individuals before symptoms appear
Company secures first commercial product with data for active and chronic TED